Table 1.

Immunophenotypes and survival in acute lymphoblastic leukemia (ALL) in children (ages 1–18) versus adults (ages 18 and older).

Immunophenotypes and survival in acute lymphoblastic leukemia (ALL) in children (ages 1–18) versus adults (ages 18 and older).
Immunophenotypes and survival in acute lymphoblastic leukemia (ALL) in children (ages 1–18) versus adults (ages 18 and older).

or Create an Account

Close Modal
Close Modal